People · Operator
Named in public records as an officer, director or promoter · active 2013–2024 · Biotechnology, Other Health Care, Other Technology, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Adient Medical, Inc. | — | Biotechnology | Series A | $18.2M | $207.1M | 2016 |
| South Campus Surgery Center Llc | — | Other Health Care | Series A | $15.3M | $1.8M | 2024 |
| Analytics2Go, Inc. | — | Other Technology | Series A | $10.1M | $36.5M | 2023 |
| East Campus Surgery Center Llc | — | Other Health Care | Seed | $3.8M | $3.3M | 2018 |
| Genomics USA, Inc. | — | Biotechnology | Pre-Seed | $837K | $46.2M | 2013 |
| Hancock Regional Surgery Center, LLC | — | Other Health Care | Pre-Seed | $791K | $7.0M | 2021 |
| PathogenDx, Inc. | — | Biotechnology | Pre-Seed | $675K | $37.3M | 2016 |
| INIA Biosciences, Inc. | — | Biotech / Pharma | Pre-Seed | $200K | $1.3M | 2023 |
MICHAEL HOGAN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside MICHAEL HOGAN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.